Page 1

GLOBAL PRECISION MEDICINE MARKET – ANALYSIS AND FORECAST (2017-2026) (Focus on Ecosystem Player, Technology, Therapeutic Applications, Patent Landscape, Country Analysis, R&D Pipeline, Product Mapping, Market Share Analysis and Competitive Insights)

Key Questions Answered in the Report: • How did the precision medicine market evolve and what is its scope in the future?

300+ COMPANIES RESEARCHED ACROSS VALUE CHAIN

What is the approach followed in the development of precision medicine solutions?

What are the key areas of interest for the development of precision medicine?

• What are the major market drivers, challenges and opportunities in the global precision medicine market? •

METICULOUS COMPILATION OF MORE THAN 800 RESEARCH HOURS

What are the key initiatives and programs launched in precision medicine market?

•  What are the key developmental strategies which are being implemented by the key players to stand out in this market? Among these strategies which strategy is currently dominating the market? • What are the precision medicine solutions provided by key companies? What are the key products in pipeline? •

EXCLUSIVE INSIGHTS FROM IN-DEPTH INTERVIEWS

Who are the key players holding significant number of patents in precision medicine market?

How is the porter’s five force affecting the industry attractiveness in precision medicine market?

What is the role of different stakeholders in value chain for precision medicine market?

• What is the total addressable market (TAM), segmental addressable market (SAM) and

CONTAINS 60 MARKET DATA TABLES AND 278 FIGURES SPREAD THROUGH 580 PAGES

the potential market opportunity of the global precision medicine market? •

What is the market share of different leading segments and sub-segments of the market for the years 2017 and 2026?

• How will each segment of the global precision medicine market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2026?

 sales@bisresearch.com

www.bisresearch.com

1


• Who are the key players dominating the global precision medicine market and their respective share in the market? •

Who are the key players dominating the precision medicine market, in different segments namely the ecosystem players, technologies, and therapeutic applications?

What are the influencing factors that may affect the market share of the key players?

•  Who are the leading ecosystem players in precision medicine market and what is their contribution to the market? What are the key drivers and challenges in each ecosystem player? • How the market has been segmented on the basis of technology? Which technology is leading and what is its share in the market? What are the key drivers and challenges in each technology? • How the market has been segmented on the basis of therapeutic application? Which therapeutic application is leading and what is its share in the market? What are the key drivers and challenges in each therapeutic application? • Which geographical location will contribute to the highest sales of precision medicine solutions and how regions have been further segmented into countries? •

Who are the key players dominating the precision medicine market, in different regions namely North America, Europe, and Asia Pacific? What are the key drivers and challenges in each geographical region?

•  How many countries are covered in each geographical region? Which country is currently dominating the precision medicine market? • What are the key strengths, weaknesses, opportunities, and threat for each key player in the precision medicine market?

 sales@bisresearch.com

www.bisresearch.com

2


TABLE OF CONTENTS

• Scope of the Report • Market segmentation • Research Methodology • Data Triangulation • Secondary Data Sources • Primary Data Sources • Top-Down Approach (Segmental Analysis) • Bottom-Up Approach (Segmental Analysis) • Assumptions and Limitations

REPORT SCOPE & METHODOLOGY

MARKET OVERVIEW

• • • • •

MARKET DYNAMICS

• • • •

COMPETITIVE INSIGHTS

INDUSTRY INSIGHTS

GLOBAL PRECISION MEDICINE MARKET BY ECOSYSTEM PLAYERS GLOBAL PRECISION MEDICINE MARKET BY TECHNOLOGY GLOBAL PRECISION MEDICINE MARKET BY REGION

Introduction Evolution of Precision Medicine Precision Medicine Approach Market Scenario Initiatives and Programs Overview Drivers Restraints Opportunities

•K  ey Developments and Strategies • Pipeline Analysis • Market Share Analysis by Company • Industry Attractiveness • Supply Chain Analysis •P  atent Landscape • Legal Requirements and Regulations •K  ey Insights • Diagnostic Companies and Clinical Laboratories • Pharmaceutical and Biotechnology Companies • Healthcare ITs and Big Data Companies • • • • • • • •

Key Insights Companion Diagnostics Molecular Diagnostics Pharmacogenomics Gene Sequencing Big Data Analytics Bioinformatics Others

GLOBAL PRECISION MEDICINE MARKET BY THERAPEUTIC APPLICATIONS • • • • • • •

Key Insights Oncology Infectious Diseases Cardiovascular Central Nervous System Immunology Others

COMPANY PROFILES • • • • • • • • • •

Abbott Laboratories Almac Group Amgen, Inc. Astellas Pharma Inc. AstraZeneca PLC ASURAGEN, INC. Bio-Rad Laboratories, Inc. BioMerieux SA BRISTOL-MYERS SQUIBB COMPANY CETICS Healthcare Technologies GmbH • Danaher Corporation • Eli-Lilly and Company • Epic Sciences, Inc. • F. Hoffmann-La Roche AG • GE Healthcare • Gilead Sciences, Inc. • GlaxoSmithKline Plc • GUARDANT HEALTH, INC • IBM Corporation • Illumina, Inc. • Intomics A/S • JOHNSON& JOHNSON • Laboratory Corporation of America • Merck KGaA • Myriad Genetics, Inc. • Novartis AG • Oracle • Pacific Biosciences of California, Inc. • Pfizer, Inc. • QIAGEN • Quest Diagnostics • Randox Laboratories • SANOFI • Sysmex Corporation •T  eva Pharmaceuticals Industries Limited. • Thermo Fischer Scientific

• Key Insights • North America • Europe • Asia Pacific • Rest of the World

 sales@bisresearch.com

VIEW COMPLETE TABLE OF CONTENTS

www.bisresearch.com

3


LIST OF TABLES 1 Initiatives and Programs

21

+A60+A1:A24+A1:A26+A1:A28+A+A1:A51 2 Security Breachment Cases/ Developments (2011-2015) 3

Developments 22

Therapeutic Applications ($Billion) 24 Global Precision Medicine Market Value, by

Players 5

Regulatory Bodies In Precision Medicine

6

Consortiums in the Precision Medicine Market

7 Alliance/Associations in the Precision Medicine Market 8

Therapeutic Applications ($Billion) 25 26

Example of Some Precision Medicine Drugs

10

Biotechnology and Pharmaceutical CompaniesRecent Key Developments

Therapeutic Applications ($Billion) 28 List of Few FDA Approved Pharmacogenomics Biomarkers in Drug Labelling 29 Global Precision Medicine Market Value, by Therapeutic Applications ($Billion) 30 List of Few Human Genetic Tests Approved by FDA

11 Global Diagnostic Tool Companies Precision Medicine Market, by Therapeutic Application, ($Billion) 12

31

Genetic Tests 33 Global Precision Medicine Market Value, by

13 Global Healthcare IT/ Big Data Companies Precision Medicine Market, by Therapeutic Application, ($Billion) 14

Service Providers- Recent Developments

15 Global Precision Medicine Market Value, by Technology Types ($Billion) 16 List of Biobanking Initiatives Across Selected OECD Countries 17 Global Precision Medicine Market Value, by Therapeutic Applications ($Billion) 18 Global Precision Medicine Market Value, by Region ($Billion) 19 Global Precision Medicine Market Value, by Therapeutic Applications ($Billion) 20 Global Precision Medicine Market Value, by Region ($Billion)

 sales@bisresearch.com

List of Few Microbial Tests Approved by FDA

32 Others Molecular Diagnostics : List of Human

Diagnostic Test Companies- Recent Key Developments

List of FDA Approved Companion diagnostics

27 Global Precision Medicine Market Value, by

($Billion) 9

Companion Diagnostics- Recent Key Developments

Global Pharma & Biotech Companies Precision Medicine Market, by Therapeutic Application,

List of Biobanks

23 Global Precision Medicine Market Value, by

Cost of Genome Sequencing

4 Competitive Landscape: Some Of The Key

Next Generation Sequencing- Recent Key

Therapeutic Applications ($Billion) 34 Global Precision Medicine Market Value, by Technology ($Billion) 35

Cancer Precision Medicine Drugs and Indications

36

Oncology- Recent Developments

37 Global Precision Medicine Market Value, by Technology ($Billion) 38 Cardiovascular Precision Medicine Drugs/Tests/ and Indications 39 Global Precision Medicine Market Value, by Technology ($Billion) 40

Central Nervous System Precision Medicine Drugs and Indications

41 Global Precision Medicine Market Value, by Technology ($Billion) 42 Infectious Diseases Precision Medicine Drugs and

www.bisresearch.com

4


LIST OF TABLES Indications 43 Global Precision Medicine Market Value, by

($Billion) 52 Europe Precision Medicine Market, by Therapeutic

Technology ($Billion) 44 Global Precision Medicine Market Value, by Technology ($Billion) 45

Other Diseases: Examples of Some Drugs

46

Recent Key Developments

47

North America Precision Medicine Market, by

Application ($Billion) 53

Key Market Players in Europe

54

Europe: Recent Key Developments

55

Asia Pacific (APAC) Precision Medicine Market, by Technology ($Billion)

56

Technology ($Billion) 48

North America Precision Medicine Market, by Therapeutic Application ($Billion)

49

Key Market Players in North America

50

North American Pharmacogenomics Market Recent

Therapeutic Applications ($Billion) 57

 sales@bisresearch.com

Key Market Players in Asia Pacific

58 Rest of the World (RoW) Precision Medicine Market, by Technology ($Billion) 59 Rest of the World (RoW) Precision Medicine

Key Developments 51 Europe Precision Medicine Market, by Technology

Asia Pacific (APAC) Precision Medicine Market, by

Market, by Therapeutic Application ($Billion) 60

Recent Key Developments

www.bisresearch.com

5


LIST OF FIGURES 1

Chronic Conditions: Key Statistics: 2016

34

Biomarkers-List of Biobanks

2

Long-Term Growth Drivers

35

Biomarker Market Dynamics

3

Global Precision Medicine Market

36

Biomarkers-Recent Key Developments

37

Sequencing Technologies in Pharmacogenomics

38

 ext Generation Sequencing: Drivers and N Challenges

39

Sequencing Applications

4 Strategies Incorporated to Expand the Global Reach 5 Global Precision Medicine Market, by Therapeutic Application, 2016 and 2026 6 Global Precision Medicine Market, by Technology, 2016 and 2026 7 Global Precision Medicine Market, by Region, 2016 and 2026

40 Global Precision Medicine Market Value, by Region ($Billion) 41 Global Precision Medicine Market Value, by Region ($Billion)

8

Global Precision Medicine Market Segmentation

9

Year Consideration

42 Drug And Companion Diagnostics Development Process

10

Share of Key Developments and Strategies

43

11

Market Share Analysis

12

Porter’s Five Forces Analysis

44 Global Precision Medicine Market Value, by Region ($Billion)

13

Supply Chain Analysis

14

Patent Analysis

15

Ecosystem Players in Precision Medicine

16 Global Precision Medicine Market Value, by Ecosystem Players ($Billion) 17

 lobal Pharma & Biotech Companies Precision G Medicine Market Value, by Region ($Billion)

18

Role Of Pharmaceuticals And Biotech Companies

19

Drug Development Process

20

 harmaceutical Companies- Drivers and P Challenges

21 Global Diagnostic Tool Companies Precision Medicine Market Value, by Region ($Billion) 22

Diagnostic Companies: Drivers and Challenges

23

Diagnostic Tests Benefits for Stakeholders

24 Global Healthcare IT / Big Data Companies Precision Medicine Market Value, by Region ($Billion) 25 Three Data Drivers of the U.S. Precision Medicine Market 26

Benefits of Big Data

27

Big Data Companies: Drivers and Challenges

28

Transformation of Medicine

29 Basic Ingredients Provided By Big Data for Precision Medicine 30

Key Players

31

Technologies in Precision Medicine

32

Functions of Biomarkers

33

Biomarker Services

 sales@bisresearch.com

Companion Diagnostics: Market Dynamics

45 Clinical Applications of Pharmacogenomics Testing 46

Mechanism of Action

47

Role of FDA in Pharmacogenomics

48 Global Precision Medicine Market Value, by Region ($Billion) 49

Types of Molecular Diagnostics Tests

50 Global Precision Medicine Market Value, by Region ($Billion) 51

Therapeutic Areas in Precision Medicine

52 Global Precision Medicine Market, by Application, 2016 and 2026 ($Million) 53 Global Precision Medicine Market Value, By Eco System Players ($Billion) 54 Global Precision Medicine Market Value, by Region ($Billion) 55

Types of Cancer

56

Government Initiatives

57

Cancer related Some Important Facts

58

Oncology: Market Dynamics

59 Global Precision Medicine Market Value, By Eco System Players ($Billion) 60 Global Precision Medicine Market Value, by Region ($Billion) 61 Global Precision Medicine Market Value, By Eco System Players ($Billion) 62 Global Precision Medicine Market Value, by Region ($Billion) 63 Global Precision Medicine Market Value, By Eco System Players ($Billion) 64 Global Precision Medicine Market Value, by

www.bisresearch.com

6


LIST OF FIGURES 92

65 Global Precision Medicine Market Value, By Eco System Players ($Billion)

 sia Pacific (APAC) Precision Medicine Market, by A Ecosystem Players, ($Billion)

93

66 Global Precision Medicine Market Value, by Region ($Billion)

 sia Pacific (APAC) Precision Medicine Market, by A Technology ($Billion)

94

67 Global Precision Medicine Market Value, By Eco System Players ($Billion)

 sia Pacific (APAC) Precision Medicine Market, by A Therapeutic Applications ($Billion)

95

Asia Pacific: Market Dynamics

96

China: Market Dynamics

97

India: Market Dynamics

Region ($Billion)

68 Global Precision Medicine Market Value, by Region ($Billion) 69 Global Precision Medicine Market Value, by Region ($Billion) 70

 orth America Precision Medicine Market, By N Region, 2015-2022 ($BILLION)

71

 orth America Precision Medicine Market, By N Ecosystem Players, 2015-2022 ($BILLION)

72

 orth America Precision Medicine Market, By N Therapeutic Applications, 2015-2022 ($BILLION)

73

North America: Market Dynamics

98 Rest of the World (RoW) Precision Medicine Market, ($Billion) 99 Rest of the World (RoW)Precision Medicine Market, by Region ($Billion) 100 Rest of the World (RoW) Precision Medicine Market, by Ecosystem Players, ($Billion) 101 Rest of the World (RoW) Precision Medicine Market, by Technology ($Billion)

74 Key regulatory Bodies and Associations

102 Rest of the World (RoW) Precision Medicine Market, by Therapeutic Applications ($Billion)

75

 orth America Precision Medicine Market, N ($Billion)

103 Middle East: Market Dynamics

76

 orth America Precision Medicine Market, by N Ecosystem Players, ($Billion)

77

The U.S. Precision Medicine Market ($Billion)

78 The U.S. Precision Medicine Market, by Ecosystem Players ($Billion) 79 The U.S. Precision Medicine Market, by Technology ($Billion) 80 The U.S. Precision Medicine Market, by Therapeutic Applications ($Billion) 81

Objectives Of The Precision Medicine Initiative

82

Canada Precision Medicine Market ($Billion)

83

Canada: Market Dynamics

84

Europe Precision Medicine Market, ($Billion)

85 Europe Precision Medicine Market, by Region ($Billion) 86 Europe Precision Medicine Market, by Ecosystem Players ($Billion)

104 Examples of some of the programs helping in the Growth of Precision Medicine Market 105 South America: Market Dynamics 106 Africa: Market Dynamics 107 Abbott Laboratories- Product Areas 108 Abbott Laboratories-Product Mapping 109 A  bbott Laboratories- Overall Financials (20142016) 110 A  bbott Laboratories- Net Revenue by Business Segment(2014-2016) 111 A  bbott Laboratories - Net Revenue by Region (2014-2016) 112 Abbott Laboratories-SWOT Analysis 113 Almac Group- Product Mapping 114 Almac Group- SWOT Analysis 115 Amgen, Inc.-Product Mapping 116 Amgen, Inc. - Overall Financials (2014-2016)

87 Europe Precision Medicine Market, by Technology ($Billion)

117 A  mgen, Inc.- Net Sales by Geographic Destination (2014-2016)

88 Europe Precision Medicine Market, by Therapeutic Applications ($Billion)

118 Amgen, Inc.-SWOT Analysis

89

Europe: Market Dynamics

90

 sia-Pacific (APAC) Precision Medicine Market, A ($Billion)

120 ANGLE plc- Net Revenue by Region (2016)

91

 sia Pacific (APAC) Precision Medicine Market, by A Region ($Billion)

 sales@bisresearch.com

119 ANGLE plc- Overall Financials (2014-2016) 121 Astellas Pharma, Inc.-Product Mapping 122 A  stellas Pharma, Inc. - Overall Financials (20142016) 123 Astellas Pharma, Inc.- Net Sales by Product Type

www.bisresearch.com

7


LIST OF FIGURES (2014-2016) 124 A  stellas Pharma, Inc.- Net Sales by Geographic Destination (2014-2016)

152 D  anaher Corporation- Net revenue share by Geography, (2014-2016) 153 Danaher Corporation-SWOT Analysis

125 Astellas Pharma, Inc.-SWOT Analysis

154 Elli-Lilly and Company -Product Mapping

126 AstraZeneca PLC-Product Mapping

155 E  li Lilly and Company - Overall Financials (20142016)

127 A  straZeneca PLC -Overall Financials ( 20142016) 128 A  straZeneca PLC- Net Revenue by Business Segment(2014-2016) 129 A  straZeneca PLC- Revenue across Different Geographies( 2014-2016)

156 E  li Lilly and Company - Net Sales by Product Type (2014-2016) 157 E  li Lilly and Company- Net Sales by Geographic Destination (2014-2016) 158 Eli Lilly and Company-SWOT Analysis

130 AstraZeneca PLC-SWOT Analysis

159 Epic Sciences, Inc. -SWOT Analysis

131 ASURAGEN, INC.-Product Mapping

160 F.Hoffmann-La Roche AG -Product Mapping

132 ASURAGEN, INC.-SWOT Analysis

161 Roche AG: Net Revenue(2014-2016)

133 Bio-Rad Laboratories, Inc. -Product Mapping

162 Roche AG- Revenue By Divisions (2014-2016)

134 B  io-Rad Laboratories, Inc. -Overall Financials ( 2014-2016)

163 R  oche AG-Revenue By Diagnostics Sub-division (2013-2016)

135 B  io-Rad Laboratories, Inc. - Net Revenue by Business Segment(2014-2016)

164 R  oche AG- Revenue By Geographical Area (2014-2016)

136 B  io-Rad Laboratories, Inc. - Revenue by Region( 2014-2016)

165 F.Hoffmann-La Roche AG-SWOT Analysis

137 Bio-Rad Laboratories, Inc.-SWOT Analysis 138 bioMérieux SA- Overall Financials(2014-2016) 139 b  ioMérieux SA- Net revenue share by Business Segment (2014-2016) 140 b  ioMérieux SA- Net revenue share by Geography(2014-2016) 141 bioMérieux SA-SWOT Analysis 142 B  RISTOL-MYERS SQUIBB COMPANY -Product Mapping 143 B  RISTOL-MYERS SQUIBB COMPANY- Overall Financials (2014-2016 144 B  RISTOL-MYERS SQUIBB COMPANY- Net Sales by Product Type (2014-2016) 145 B  RISTOL-MYERS SQUIBB COMPANY- Net Sales by Geographic Destination (2014-2016) 146 B  RISTOL-MYERS SQUIBB COMPANY-SWOT Analysis

166 GE Healthcare -Product Mapping 167 GE Corporation-Overall Financials (2014-2016) 168 G  E Corporation- Net Revenue by Business Segments (2014-2016) 169 G  E Corporation- Net Revenue by Geography (2014-2016) 170 Percentage of Revenues by Healthcare Sub Segments - 2016 171 GE Healthcare-SWOT Analysis 172 Gilead Sciences, Inc. -Product Mapping 173 G  ilead Sciences, Inc.- Overall Financials (20142016) 174 G  ilead Sciences, Inc.- Revenue Across Different Geographies(2014-2016) 175 Gilead Sciences, Inc.-SWOT Analysis 176 GlaxoSmithKline Plc -Product Mapping 177 GlaxoSmithKline: Overall Financials (2013-2016)

147 C  ETICS Healthcare Technologies GmbH -Product Mapping

178 G  laxoSmithKline- Net Revenue by Business Segments (2013-2016)

148 C  ETICS Healthcare Technologies GmbH -SWOT Analysis

179 G  laxoSmithKline- Net Revenue by Geography (2013-2015)

149 Danaher Corporation -Product Mapping

180 G  laxoSmithKline-Net Revenue by Geography (2016)

150 D  anaher Corporation- Overall Financials(2014-2016) 151 D  anaher Corporation- Net revenue share by Business Segments(2014-2016)

 sales@bisresearch.com

181 GlaxoSmithKline-SWOT Analysis 182 IBM Corporation-Product Mapping 183 IBM-Overall Financials (2014-2016)

www.bisresearch.com

8


LIST OF FIGURES 184 I BM- Net Revenue by Business Segments(2014-2016)

213 M  erck & CO., Inc. KGaA- Net Revenue by Geography(2015-2016)

185 IBM-Net Revenue by Geography(2014-2016)

214 Merck & CO., Inc. KGaA, -SWOT Analysis

186 IBM Corporation-SWOT Analysis

215 Myriad Genetics, Inc.-Product Mapping

187 Illumina, Inc.-Product Mapping

216 M  yriad Genetics, Inc.- Overall Financials(2014-2016)

188 Illumina, Inc.-Overall Financials(2014-2016) 189 I llumina, Inc.- Net Revenue by Business Segment(2014-2016) 190 I llumina, Inc.- Revenue across Different Geographies(2014-2016)

217 M  yriad Genetics, Inc.- Net Revenue by Business Segments (2014-2016) 218 Myriad Genetics, Inc. -SWOT Analysis 219 Novartis AG-Product Mapping

191 Illumina, Inc.-SWOT Analysis

220 Novartis AG- Overall Financials (2014-2016)

192 Intomics A/S-Product Mapping

221 N  ovartis AG- Net Revenue by Business Segments (2013-2014)

193 Intomics A/S-SWOT Analysis 194 Johnson&Johnson-Product Mapping 195 J OHNSON & JOHNSON- Overall Financials(2014-2016) 196 J OHNSON & JOHNSON-Net Revenue By Business Segment(2014-2016) 197 J OHNSON & JOHNSON-Net Revenue By Geography(2014-2016)

222 N  ovartis AG- Net Revenue by Business Segments (2015-2016) 223 N  ovartis AG- Net Revenue by Geography (20132016) 224 Novartis AG -SWOT Analysis 225 Oracle-Product Mapping 226 Oracle- Overall Financials (2014-2016)

198 J OHNSON & JOHNSON- Net Revenue by Medical Devices Business Segment(2014-2016)

227 O  racle- Net Revenue by Business Segments (2014-2016)

199 J OHNSON & JOHNSON- Net Revenue by Orthopedic Sub segment(2014-2016)

228 Oracle-Net Revenue by Geography(2014-2016)

200 JOHNSON & JOHNSON-SWOT Analysis 201 L  aboratory Corporation of America-Product Mapping 202 L  aboratory corporation of America-Overall Financials (2014-2016) 203 L  aboratory Corporation of America- Net Revenue by Business Segments(2014-2016) 204 L  aboratory Corporation of America- Net Revenue by Business Segment and Geography(2014-2016) 205 L  aboratory Corporation of America-SWOT Analysis 206 MDX Health, Inc.-Overall Financials (2014-2016) 207 MDX Health, Inc.-SWOT Analysis 208 M  enarini Silicon Biosystems, Inc.-Product Mapping 209 Menarini Silicon Biosystems, Inc.-SWOT Analysis 210 M  erck & CO., Inc. KGaA- Overall Financials(2014-2016) 211 M  erck & CO., Inc. KGaA- Net Revenue by Business Segments (2014-2016) 212 M  erck & CO., Inc. Kga-Net Revenue by Geography(2014)

 sales@bisresearch.com

229 Oracle -SWOT Analysis 230 P  acific Biosciences of California, Inc.-Product Mapping 231 P  acific Biosciences of California, Inc.- Overall Financials (2014-2016) 232 P  acific Biosciences of California, Inc.- Net Revenue by Business Segment (2014-2015) 233 P  acific Biosciences, Inc.- Net Revenue by Business Sub-Segment (2014-2016) 234 P  acific Biosciences of California, Inc.- Net Revenue by Region (2014-2015) 235 P  acific Biosciences of California, Inc.-SWOT Analysis 236 Partek, Inc.-Product Mapping 237 Partek, Inc.-SWOT Analysis 238 Pfizer, Inc.-Product Mapping 239 Pfizer- Overall Financials (2013-2016) 240 Pfizer- Net Revenue by Geography (2013-2016) 241 P  fizer- Net Revenue by Business Segments (2013-2014) 242 P  fizer- Net Revenue by Business Segments (2015-2016) 243 Pfizer, Inc.-SWOT Analysis

www.bisresearch.com

9


LIST OF FIGURES 244 QIAGEN-Product Mapping 245 QIAGEN- Overall Financials (2014-2016) 246 QIAGEN- Net Revenue by Region (2014-2016) 247 QIAGEN-SWOT Analysis 248 Quest Diagnostics-Product Mapping 249 Q  uest Diagnostics- Overall Financials (20142016) 250 Q  uest Diagnostics- Net Revenue by Business Segments(2014-2016) 251 Quest Diagnostics-SWOT Analysis 252 Randox Laboratories-Product Mapping 253 Randox Laboratories-SWOT Analysis 254 SANOFI-Product Mapping 255 SANOFI- Overall Financials (2014-2016) 256 S  ANOFI: Net Sales by Business Segments (2014-2016) 257 S  ANOFI- Net Sales by Geographic Destination (2014-2016) 258 SANOFI: Net Sales by Franchise (2014-2016)

263 S  ysmex Corporation- Revenue by Region(2014-2016) 264 Sysmex Corporation-SWOT Analysis 265 T  eva Pharmaceuticals Industries Limited.-Product Mapping 267 T  eva Pharmaceuticals Industries Limited.-R&D Pipeline 268 T  eva Pharmaceutical Industries Limited- Overall Financials(2013-2016) 269 T  eva Pharmaceutical Industries Limited- Net Revenue by Business Segments(2013-2016) 270 T  eva Pharmaceutical Industries Limited- Net Revenue by Geography(2013-2016) 271 T  eva Pharmaceutical Industries Limited-SWOT Analysis 272 Thermo Fisher Scientific-Product Mapping 273 T  hermo Fisher Scientific- Overall Financials (2014-2016) 274 T  hermo Fisher Scientific- Net Revenue by Business Segment (2014-2016)

259 SANOFI-SWOT Analysis

275 T  hermo Fisher Scientific-Net Revenue by Region (2014-2016)

260 Sysmex Corporation-Product Mapping

276 Thermo Fisher Scientific-SWOT Analysis

261 S  ysmex Corporation- Overall Financials (20142016)

277 TROVAGENE, INC.-Product Mapping

262 S  ysmex Corporation- Revenue by Business Segment (2014-2016)

 sales@bisresearch.com

278 T  ROVAGENE, INC.-Overall Financials (20142016) 279 TROVAGENE, INC.-SWOT Analysis

www.bisresearch.com

10


1

1.1 Scope of the Report

Research Scope & BIS Methodology

The report constitutes an in-depth study of the global precision medicine market, including a thorough analysis of the products across different regions. The study also presents a detailed analysis of the market trends, and the market size for the period 2016-2026, wherein 2016 is the base year, and the years from 2017 to 2026 constitute the forecast period. The report covers all the prevalent trends which are expected to play a significant role in the growth of the market over the forecast period. It also highlights various drivers, restraints, challenges, and opportunities which are expected to influence the market’s growth during the forecast period. The report is focused on the global precision medicine market; ecosystem and technology, application, their market dynamics, growth prospect mapping, SWOT analysis, Porter’s Five Forces, market share analysis, pipeline analysis, and country-wise analysis.

The study provides a holistic perspective on the market growth, in terms of revenue estimates, across different geographies which include North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW). The report provides cross-sectional analysis of the global precision medicine market in terms of market estimates, and projections, for all the segments across different geographical regions. The regions have been further segmented to cover the in-depth country level analysis. The North American region has been segmented into the U.S., and Canada. Similarly, Europe has been further segmented into the U.K., Germany, France, Spain, Italy, and Rest of Europe. Asia Pacific has been segmented into China, Japan, Australia, India, Singapore, and Rest of Asia Pacific. Moreover, Rest of the World (RoW) has been further segmented into Middle East Africa, and Latin America.

1.2 BIS Research Market Research Methodology The research methodology design adopted for this specific study includes a mix of data collected from primary and secondary sources. Both primary sources (in-house experts, industry leaders and market players) and secondary sources (a host of paid and unpaid databases) along with analytical tools have been used exhaustively to build the forecast and predictive models.

 sales@bisresearch.com

www.bisresearch.com

11


Figure 1

BIS Research Market Research Methodology RESEARCH APPROACH

SECONDARY RESEARCH

1.

STUDYING THE MARKET STRUCTURE

PRIMARY RESEARCH

DATABASE FOR KEY INDUSTRY PARTICIPANTS (DKIP) PREPARATION

The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various vendors providing technology solutions, associated service providers, and system integrators operating in the targeted regions. E.g. CIO’s, VP, Director New Product Development, Director –operations

Mainly used to obtain key information about the industry’s value chain, the total pool of key players

IDENTIFY MARKET, TECHNOLOGY AND COMPETITOR TRENDS

2.

DISCUSSION GUIDE PREPARATION

Understand market classification, and segmentation according to industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives

A detailed questionnaire is shared with the primary respondent covering all the aspects related to the report topic

INTEGRATE INFORMATION

Appointments are scheduled with CIO’s, VP – healthcare companies, Director with prior appointments and the discussion guide is shared with the primary respondent prior to the call

3.

Integrate information within relevant documents to form launch pad for primary research VENDORS

CONSULTANT

RESELLERS

4.

MSP’s

END USER

CALL EXECUTION

A roundtable discussion is held with the KIP with the aim to gather first hand information about the technology, recent developments in the technology and future outlook/ growth or decline

5.

POTENTIAL RESPONDENTS

SCHEDULING AN APPOINTMENT

DOCUMENTATION

The interview is recorded and the information gathered in put on the drawing board with the information collected through secondary research.

BIS Research Analysis

Primary Data Sources

The key data points taken from Primary Sources includes:

• Validation and Triangulation of all the numbers and graphs

• Validation of report segmentation and key qualitative findings

• Understanding the competitive landscape

•  Understanding and considering the market dynamics factors for various market segment and sub-segment

• Validation of impact analysis of macro and micro factors in different countries

• Percentage split of individual markets for geographical analysis

Secondary Data Sources

 The research study involves the usage of extensive secondary sources such as databases, company websites, and annual reports, among others.

 sales@bisresearch.com

www.bisresearch.com

12


The following figure exhibits key secondary data sources considered in this report:

Figure 2

Secondary Data Sources STOCK ANALYST WEBSITES

Seeking Alpha Yahoo Finance Wiki Finance The Wall Street Journal

COMPANY SOURCES Annual Reports Press Releases SEC Filings Investor Presentations Financial Disclosures

SECONDARY DATA SOURCES GOVERNMENT AND REGULATORY SOURCES The Centre for Disease Control (CDC) The World Health Organization (WHO) The National Health Services (NHS) The National Center for Biotechnology Information (NCBI) The Food & Drug Administration of United States (U.S. FDA)

PUBLIC AND PRIVATE DATABASES Medline PubMed National Library of Medicine ProQuest Thin Database CMS Datasets Medicare Beneficiaries Database Oxon Epidemiology

BIS Research Analysis

The key data points taken from secondary sources include:

• Segmentation breakups, split-ups, and percentage shares

• Data for market value

• Key industry trends of the top players of the market

• Q  ualitative insights into various aspects of the market, key trends, and emerging areas of innovation

• Quantitative data for mathematical and statistical calculations.

 sales@bisresearch.com

www.bisresearch.com

13

Global Precision Medicine Market  

The report is focused on the global precision medicine market; ecosystem and technology, application, their market dynamics, growth prospect...

Global Precision Medicine Market  

The report is focused on the global precision medicine market; ecosystem and technology, application, their market dynamics, growth prospect...

Advertisement